Share Price and Basic Stock Data
Last Updated: January 28, 2026, 11:41 am
| PEG Ratio | 0.47 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Crestchem Ltd, operating in the organic chemicals sector, reported a market capitalization of ₹26.4 Cr and a share price of ₹88.0. The company has shown significant revenue growth over the years, with sales rising from ₹6.15 Cr in FY 2020 to ₹16.66 Cr in FY 2023, and projected sales of ₹24.98 Cr for FY 2025. The quarterly sales figures also indicate a positive trend, with the latest quarter ending September 2023 recording sales of ₹4.49 Cr, up from ₹3.78 Cr in June 2023. This growth trajectory reflects the company’s ability to capitalize on market opportunities, driven by a robust demand for organic chemicals. Crestchem’s quarterly sales are expected to fluctuate, as seen in the recorded sales of ₹7.36 Cr in December 2023, highlighting potential seasonal variations. The company’s operational performance is further evidenced by its operating profit margin (OPM), which stood at 8.48% in FY 2025, demonstrating effective cost management despite market challenges.
Profitability and Efficiency Metrics
The profitability metrics of Crestchem Ltd are noteworthy, with a reported Return on Equity (ROE) of 44.1% and Return on Capital Employed (ROCE) of 59.9%, indicating efficient use of shareholders’ equity and capital. The net profit for FY 2025 is recorded at ₹2.73 Cr, up from ₹2.15 Cr in FY 2024, showcasing a consistent increase in profitability. The company has maintained a high interest coverage ratio (ICR) of 271.82x, reflecting its ability to meet interest obligations comfortably, bolstered by zero borrowings as of the latest reporting. The OPM of 8.48% aligns with industry norms, suggesting that while Crestchem is managing its costs effectively, it may still face competitive pressures in maintaining this margin against larger players in the organic chemicals sector. The net profit margin of 10.87% for FY 2025 further emphasizes the company’s strong profitability relative to its sales.
Balance Sheet Strength and Financial Ratios
Crestchem’s balance sheet demonstrates significant strength, with total borrowings reported at ₹0.00 Cr, indicating a debt-free status. This is complemented by reserves of ₹5.07 Cr, which have grown from ₹4.48 Cr in FY 2024, showcasing the company’s ability to retain earnings and strengthen its capital base. The company’s current ratio stands at 1.44, indicating a solid liquidity position, while the quick ratio mirrors this stability, also at 1.44. The price-to-book value (P/BV) ratio is reported at 8.29x, which suggests that the market has high expectations for the company’s growth relative to its book value. Additionally, the asset turnover ratio of 2.84% indicates effective utilization of assets to generate revenue. However, the company should monitor its high P/BV against industry benchmarks to ensure that it does not indicate overvaluation.
Shareholding Pattern and Investor Confidence
The shareholding structure of Crestchem Ltd reveals a diverse ownership base, with promoters holding 29.69% of shares, while public shareholders constitute the majority at 70.19%. The slight decline in promoter shareholding from 32.21% in March 2025 to the current level may raise questions about long-term confidence from the founding group. Conversely, institutional investors (DIIs) hold a minimal stake of 0.13%, indicating limited institutional interest in the company. The total number of shareholders has increased to 12,851, reflecting growing retail interest in Crestchem. This broad base of public investors can provide stability; however, the lack of substantial institutional ownership may expose the company to volatility in market sentiment. The increasing public ownership, from 67.66% in March 2025 to its current level, suggests that retail investors are finding value in Crestchem’s performance.
Outlook, Risks, and Final Insight
Crestchem Ltd is positioned for continued growth, driven by its strong profitability metrics and debt-free balance sheet. However, risks remain, particularly related to fluctuations in raw material prices and potential market competition, which could impact margins and sales growth. The company’s operational efficiency, as evidenced by its high ROE and ROCE, provides a buffer against such risks. The ongoing expansion of its sales and profitability could attract more institutional investors, improving overall market confidence. Nonetheless, the decline in promoter shareholding raises concerns about long-term strategic direction. If Crestchem can leverage its strong financial position to innovate and expand its product offerings, it may enhance its market share. Conversely, failure to address competitive pressures could hinder its growth trajectory. Thus, stakeholders should monitor these dynamics closely as they unfold.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 58.9 Cr. | 165 | 437/135 | 137 | 392 | 0.06 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,020 Cr. | 8,855 | 14,250/8,150 | 50.8 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 27.0 Cr. | 90.0 | 329/84.1 | 13.4 | 26.9 | 1.11 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 205 Cr. | 257 | 435/163 | 11.4 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,481.50 Cr | 1,439.07 | 56.19 | 334.84 | 0.44% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.89 | 5.17 | 2.87 | 3.78 | 4.49 | 7.36 | 5.63 | 5.25 | 7.80 | 4.80 | 7.23 | 5.03 | 7.19 |
| Expenses | 3.74 | 4.71 | 2.83 | 3.51 | 4.08 | 6.13 | 4.78 | 4.49 | 6.53 | 4.15 | 6.63 | 4.67 | 6.58 |
| Operating Profit | 0.15 | 0.46 | 0.04 | 0.27 | 0.41 | 1.23 | 0.85 | 0.76 | 1.27 | 0.65 | 0.60 | 0.36 | 0.61 |
| OPM % | 3.86% | 8.90% | 1.39% | 7.14% | 9.13% | 16.71% | 15.10% | 14.48% | 16.28% | 13.54% | 8.30% | 7.16% | 8.48% |
| Other Income | 0.03 | 0.03 | 0.05 | 0.05 | 0.06 | 0.06 | 0.09 | 0.08 | 0.12 | 0.09 | 0.14 | 0.13 | 0.15 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Profit before tax | 0.17 | 0.48 | 0.08 | 0.32 | 0.46 | 1.28 | 0.93 | 0.83 | 1.38 | 0.73 | 0.72 | 0.47 | 0.74 |
| Tax % | 23.53% | 27.08% | 12.50% | 25.00% | 26.09% | 28.91% | 27.96% | 27.71% | 28.26% | 27.40% | 15.28% | 25.53% | 25.68% |
| Net Profit | 0.12 | 0.36 | 0.07 | 0.24 | 0.34 | 0.91 | 0.66 | 0.60 | 1.00 | 0.52 | 0.61 | 0.35 | 0.54 |
| EPS in Rs | 0.40 | 1.20 | 0.23 | 0.80 | 1.13 | 3.03 | 2.20 | 2.00 | 3.33 | 1.73 | 2.03 | 1.17 | 1.80 |
Last Updated: December 27, 2025, 10:04 am
Below is a detailed analysis of the quarterly data for Crestchem Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 7.19 Cr.. The value appears strong and on an upward trend. It has increased from 5.03 Cr. (Jun 2025) to 7.19 Cr., marking an increase of 2.16 Cr..
- For Expenses, as of Sep 2025, the value is 6.58 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.67 Cr. (Jun 2025) to 6.58 Cr., marking an increase of 1.91 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.61 Cr.. The value appears strong and on an upward trend. It has increased from 0.36 Cr. (Jun 2025) to 0.61 Cr., marking an increase of 0.25 Cr..
- For OPM %, as of Sep 2025, the value is 8.48%. The value appears strong and on an upward trend. It has increased from 7.16% (Jun 2025) to 8.48%, marking an increase of 1.32%.
- For Other Income, as of Sep 2025, the value is 0.15 Cr.. The value appears strong and on an upward trend. It has increased from 0.13 Cr. (Jun 2025) to 0.15 Cr., marking an increase of 0.02 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.74 Cr.. The value appears strong and on an upward trend. It has increased from 0.47 Cr. (Jun 2025) to 0.74 Cr., marking an increase of 0.27 Cr..
- For Tax %, as of Sep 2025, the value is 25.68%. The value appears to be increasing, which may not be favorable. It has increased from 25.53% (Jun 2025) to 25.68%, marking an increase of 0.15%.
- For Net Profit, as of Sep 2025, the value is 0.54 Cr.. The value appears strong and on an upward trend. It has increased from 0.35 Cr. (Jun 2025) to 0.54 Cr., marking an increase of 0.19 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.80. The value appears strong and on an upward trend. It has increased from 1.17 (Jun 2025) to 1.80, marking an increase of 0.63.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:54 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.42 | 0.09 | 0.13 | 0.14 | 0.05 | 0.10 | 6.15 | 7.62 | 7.90 | 16.66 | 21.18 | 24.98 | 24.25 |
| Expenses | 0.36 | 0.23 | 0.18 | 0.34 | 0.29 | 0.26 | 5.59 | 6.95 | 7.15 | 15.84 | 18.40 | 21.66 | 22.03 |
| Operating Profit | 0.06 | -0.14 | -0.05 | -0.20 | -0.24 | -0.16 | 0.56 | 0.67 | 0.75 | 0.82 | 2.78 | 3.32 | 2.22 |
| OPM % | 14.29% | -155.56% | -38.46% | -142.86% | -480.00% | -160.00% | 9.11% | 8.79% | 9.49% | 4.92% | 13.13% | 13.29% | 9.15% |
| Other Income | 0.03 | 0.89 | 0.19 | 0.08 | 0.03 | 0.02 | 0.03 | 0.05 | 0.08 | 0.15 | 0.26 | 0.44 | 0.51 |
| Interest | 0.03 | 0.02 | 0.02 | 0.04 | 0.01 | 0.01 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 | 0.05 | 0.00 |
| Depreciation | 0.08 | 0.05 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.05 | 0.05 | 0.07 |
| Profit before tax | -0.02 | 0.68 | 0.12 | -0.16 | -0.22 | -0.16 | 0.57 | 0.68 | 0.78 | 0.94 | 2.98 | 3.66 | 2.66 |
| Tax % | 0.00% | 10.29% | 25.00% | 0.00% | -13.64% | 0.00% | 22.81% | 14.71% | 26.92% | 26.60% | 27.85% | 25.41% | |
| Net Profit | -0.03 | 0.61 | 0.09 | -0.16 | -0.19 | -0.17 | 0.44 | 0.57 | 0.57 | 0.69 | 2.15 | 2.73 | 2.02 |
| EPS in Rs | -0.10 | 2.03 | 0.30 | -0.53 | -0.63 | -0.57 | 1.47 | 1.90 | 1.90 | 2.30 | 7.17 | 9.10 | 6.73 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.98% | 10.99% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 2133.33% | -85.25% | -277.78% | -18.75% | 10.53% | 358.82% | 29.55% | 0.00% | 21.05% | 211.59% | 26.98% |
| Change in YoY Net Profit Growth (%) | 0.00% | -2218.58% | -192.53% | 259.03% | 29.28% | 348.30% | -329.28% | -29.55% | 21.05% | 190.54% | -184.62% |
Crestchem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 76% |
| 5 Years: | 32% |
| 3 Years: | 47% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 44% |
| 3 Years: | 69% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 43% |
| 3 Years: | 42% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 44% |
| 3 Years: | 45% |
| Last Year: | 44% |
Last Updated: September 5, 2025, 3:06 pm
Balance Sheet
Last Updated: December 10, 2025, 4:08 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Reserves | -2.59 | -2.09 | -2.00 | -2.16 | -2.36 | -2.53 | -2.08 | -1.51 | -0.94 | -0.25 | 1.90 | 4.48 | 5.07 |
| Borrowings | 0.40 | 0.37 | 0.35 | 0.60 | 0.14 | 0.28 | 0.02 | 0.63 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.49 | 0.22 | 0.05 | 0.05 | 0.04 | 0.14 | 1.35 | 0.87 | 0.96 | 2.04 | 2.24 | 3.07 | 5.48 |
| Total Liabilities | 1.30 | 1.50 | 1.40 | 1.49 | 0.82 | 0.89 | 2.29 | 2.99 | 3.29 | 4.79 | 7.14 | 10.55 | 13.55 |
| Fixed Assets | 0.46 | 0.04 | 0.04 | 0.04 | 0.11 | 0.12 | 0.10 | 0.14 | 0.11 | 0.10 | 0.17 | 0.26 | 0.23 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.84 | 1.46 | 1.36 | 1.45 | 0.71 | 0.77 | 2.19 | 2.85 | 3.18 | 4.69 | 6.97 | 10.29 | 13.32 |
| Total Assets | 1.30 | 1.50 | 1.40 | 1.49 | 0.82 | 0.89 | 2.29 | 2.99 | 3.29 | 4.79 | 7.14 | 10.55 | 13.55 |
Below is a detailed analysis of the balance sheet data for Crestchem Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Reserves, as of Sep 2025, the value is 5.07 Cr.. The value appears strong and on an upward trend. It has increased from 4.48 Cr. (Mar 2025) to 5.07 Cr., marking an increase of 0.59 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5.48 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.07 Cr. (Mar 2025) to 5.48 Cr., marking an increase of 2.41 Cr..
- For Total Liabilities, as of Sep 2025, the value is 13.55 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.55 Cr. (Mar 2025) to 13.55 Cr., marking an increase of 3.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.23 Cr.. The value appears to be declining and may need further review. It has decreased from 0.26 Cr. (Mar 2025) to 0.23 Cr., marking a decrease of 0.03 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 13.32 Cr.. The value appears strong and on an upward trend. It has increased from 10.29 Cr. (Mar 2025) to 13.32 Cr., marking an increase of 3.03 Cr..
- For Total Assets, as of Sep 2025, the value is 13.55 Cr.. The value appears strong and on an upward trend. It has increased from 10.55 Cr. (Mar 2025) to 13.55 Cr., marking an increase of 3.00 Cr..
Notably, the Reserves (5.07 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.34 | -0.51 | -0.40 | -0.80 | -0.38 | -0.44 | 0.54 | 0.04 | 0.48 | 0.82 | 2.78 | 3.32 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 356.31 | 0.00 | 336.92 | 469.29 | 730.00 | 292.00 | 71.81 | 67.54 | 41.58 | 0.44 | 26.37 | 37.41 |
| Inventory Days | 0.00 | 60.83 | 0.00 | 73.00 | 0.00 | 182.50 | 0.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | 60.83 | 73.00 | 365.00 | 91.06 | ||||||||
| Cash Conversion Cycle | 356.31 | 0.00 | 336.92 | 469.29 | 730.00 | 109.50 | -18.50 | 67.54 | 41.58 | 0.44 | 26.37 | 37.41 |
| Working Capital Days | -234.64 | -1,987.22 | -645.77 | -1,016.79 | 438.00 | -292.00 | 3.56 | 12.93 | -2.77 | -36.81 | -1.21 | 8.47 |
| ROCE % | 1.30% | -13.40% | 10.65% | -8.60% | -18.92% | -19.61% | 67.46% | 45.75% | 35.96% | 37.40% | 78.17% | 59.94% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 9.09 | 7.15 | 2.31 | 1.89 | 19.91 |
| Diluted EPS (Rs.) | 9.09 | 7.15 | 2.31 | 1.89 | 19.91 |
| Cash EPS (Rs.) | 9.26 | 7.31 | 2.39 | 1.98 | 1.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 24.92 | 16.33 | 9.18 | 6.87 | 4.97 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 24.92 | 16.33 | 9.18 | 6.87 | 4.97 |
| Dividend / Share (Rs.) | 1.00 | 0.50 | 0.00 | 0.00 | 0.00 |
| Revenue From Operations / Share (Rs.) | 83.59 | 70.85 | 55.76 | 26.49 | 25.47 |
| PBDIT / Share (Rs.) | 12.41 | 10.11 | 3.23 | 2.74 | 2.38 |
| PBIT / Share (Rs.) | 12.23 | 9.96 | 3.16 | 2.66 | 2.30 |
| PBT / Share (Rs.) | 12.19 | 9.93 | 3.13 | 2.60 | 2.24 |
| Net Profit / Share (Rs.) | 9.09 | 7.15 | 2.31 | 1.89 | 1.91 |
| PBDIT Margin (%) | 14.84 | 14.27 | 5.80 | 10.35 | 9.33 |
| PBIT Margin (%) | 14.63 | 14.05 | 5.66 | 10.02 | 9.02 |
| PBT Margin (%) | 14.58 | 14.01 | 5.60 | 9.82 | 8.81 |
| Net Profit Margin (%) | 10.87 | 10.09 | 4.14 | 7.13 | 7.51 |
| Return on Networth / Equity (%) | 36.46 | 43.80 | 25.18 | 27.53 | 38.46 |
| Return on Capital Employeed (%) | 48.63 | 60.53 | 34.26 | 38.57 | 44.70 |
| Return On Assets (%) | 25.85 | 30.04 | 14.48 | 17.22 | 19.14 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.12 | 0.42 |
| Asset Turnover Ratio (%) | 2.84 | 3.56 | 4.14 | 2.53 | 2.89 |
| Current Ratio (X) | 1.44 | 1.04 | 0.60 | 0.95 | 1.85 |
| Quick Ratio (X) | 1.44 | 1.04 | 0.60 | 0.95 | 1.85 |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 11553.39 | 2181.02 | 1235.35 |
| Interest Coverage Ratio (X) | 271.82 | 430.21 | 98.75 | 52.20 | 44.41 |
| Interest Coverage Ratio (Post Tax) (X) | 200.07 | 305.40 | 71.56 | 36.98 | 36.75 |
| Enterprise Value (Cr.) | 61.25 | 34.07 | 35.86 | 12.56 | 7.51 |
| EV / Net Operating Revenue (X) | 2.44 | 1.60 | 2.14 | 1.58 | 0.98 |
| EV / EBITDA (X) | 16.45 | 11.23 | 36.95 | 15.26 | 10.53 |
| MarketCap / Net Operating Revenue (X) | 2.47 | 1.61 | 2.20 | 1.55 | 1.03 |
| Price / BV (X) | 8.29 | 6.98 | 13.34 | 5.97 | 5.27 |
| Price / Net Operating Revenue (X) | 2.47 | 1.61 | 2.20 | 1.55 | 1.03 |
| EarningsYield | 0.04 | 0.06 | 0.01 | 0.04 | 0.07 |
After reviewing the key financial ratios for Crestchem Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 9.09. This value is within the healthy range. It has increased from 7.15 (Mar 24) to 9.09, marking an increase of 1.94.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.09. This value is within the healthy range. It has increased from 7.15 (Mar 24) to 9.09, marking an increase of 1.94.
- For Cash EPS (Rs.), as of Mar 25, the value is 9.26. This value is within the healthy range. It has increased from 7.31 (Mar 24) to 9.26, marking an increase of 1.95.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.92. It has increased from 16.33 (Mar 24) to 24.92, marking an increase of 8.59.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.92. It has increased from 16.33 (Mar 24) to 24.92, marking an increase of 8.59.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 1.00, marking an increase of 0.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 83.59. It has increased from 70.85 (Mar 24) to 83.59, marking an increase of 12.74.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.41. This value is within the healthy range. It has increased from 10.11 (Mar 24) to 12.41, marking an increase of 2.30.
- For PBIT / Share (Rs.), as of Mar 25, the value is 12.23. This value is within the healthy range. It has increased from 9.96 (Mar 24) to 12.23, marking an increase of 2.27.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 9.93 (Mar 24) to 12.19, marking an increase of 2.26.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 9.09. This value is within the healthy range. It has increased from 7.15 (Mar 24) to 9.09, marking an increase of 1.94.
- For PBDIT Margin (%), as of Mar 25, the value is 14.84. This value is within the healthy range. It has increased from 14.27 (Mar 24) to 14.84, marking an increase of 0.57.
- For PBIT Margin (%), as of Mar 25, the value is 14.63. This value is within the healthy range. It has increased from 14.05 (Mar 24) to 14.63, marking an increase of 0.58.
- For PBT Margin (%), as of Mar 25, the value is 14.58. This value is within the healthy range. It has increased from 14.01 (Mar 24) to 14.58, marking an increase of 0.57.
- For Net Profit Margin (%), as of Mar 25, the value is 10.87. This value exceeds the healthy maximum of 10. It has increased from 10.09 (Mar 24) to 10.87, marking an increase of 0.78.
- For Return on Networth / Equity (%), as of Mar 25, the value is 36.46. This value is within the healthy range. It has decreased from 43.80 (Mar 24) to 36.46, marking a decrease of 7.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 48.63. This value is within the healthy range. It has decreased from 60.53 (Mar 24) to 48.63, marking a decrease of 11.90.
- For Return On Assets (%), as of Mar 25, the value is 25.85. This value is within the healthy range. It has decreased from 30.04 (Mar 24) to 25.85, marking a decrease of 4.19.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.84. It has decreased from 3.56 (Mar 24) to 2.84, marking a decrease of 0.72.
- For Current Ratio (X), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 1.5. It has increased from 1.04 (Mar 24) to 1.44, marking an increase of 0.40.
- For Quick Ratio (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.44, marking an increase of 0.40.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 271.82. This value is within the healthy range. It has decreased from 430.21 (Mar 24) to 271.82, marking a decrease of 158.39.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 200.07. This value is within the healthy range. It has decreased from 305.40 (Mar 24) to 200.07, marking a decrease of 105.33.
- For Enterprise Value (Cr.), as of Mar 25, the value is 61.25. It has increased from 34.07 (Mar 24) to 61.25, marking an increase of 27.18.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.44. This value is within the healthy range. It has increased from 1.60 (Mar 24) to 2.44, marking an increase of 0.84.
- For EV / EBITDA (X), as of Mar 25, the value is 16.45. This value exceeds the healthy maximum of 15. It has increased from 11.23 (Mar 24) to 16.45, marking an increase of 5.22.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has increased from 1.61 (Mar 24) to 2.47, marking an increase of 0.86.
- For Price / BV (X), as of Mar 25, the value is 8.29. This value exceeds the healthy maximum of 3. It has increased from 6.98 (Mar 24) to 8.29, marking an increase of 1.31.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has increased from 1.61 (Mar 24) to 2.47, marking an increase of 0.86.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.04, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Crestchem Ltd:
- Net Profit Margin: 10.87%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 48.63% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 36.46% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 200.07
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.4 (Industry average Stock P/E: 56.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.87%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Sr. No.550/1, Sub Plot Number 12, Mehsana Dist. Gujarat 382715 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dipak Narendraprasad Patel | Promoter, Chairman & Managing Director |
| Mr. Nitinkumar Shantilal Shah | Non Exe. & Ind. Director |
| Mrs. Rinkal Maulik Jasani | Non Exe. Women Independent Director |
| Mrs. Priyankaben M Patel | Ind. Non-Executive Director |
| Mr. Jignesh A Shah | Ind. Non-Executive Director |
| Mr. Nirmit Dipak Patel | Executive Director |
FAQ
What is the intrinsic value of Crestchem Ltd?
Crestchem Ltd's intrinsic value (as of 28 January 2026) is ₹165.59 which is 83.99% higher the current market price of ₹90.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹27.0 Cr. market cap, FY2025-2026 high/low of ₹329/84.1, reserves of ₹5.07 Cr, and liabilities of ₹13.55 Cr.
What is the Market Cap of Crestchem Ltd?
The Market Cap of Crestchem Ltd is 27.0 Cr..
What is the current Stock Price of Crestchem Ltd as on 28 January 2026?
The current stock price of Crestchem Ltd as on 28 January 2026 is ₹90.0.
What is the High / Low of Crestchem Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Crestchem Ltd stocks is ₹329/84.1.
What is the Stock P/E of Crestchem Ltd?
The Stock P/E of Crestchem Ltd is 13.4.
What is the Book Value of Crestchem Ltd?
The Book Value of Crestchem Ltd is 26.9.
What is the Dividend Yield of Crestchem Ltd?
The Dividend Yield of Crestchem Ltd is 1.11 %.
What is the ROCE of Crestchem Ltd?
The ROCE of Crestchem Ltd is 59.9 %.
What is the ROE of Crestchem Ltd?
The ROE of Crestchem Ltd is 44.1 %.
What is the Face Value of Crestchem Ltd?
The Face Value of Crestchem Ltd is 10.0.